• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中巨噬细胞的功能多样性——不止炎症那么简单。

Macrophage functional diversity in NAFLD - more than inflammation.

机构信息

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Nat Rev Endocrinol. 2022 Aug;18(8):461-472. doi: 10.1038/s41574-022-00675-6. Epub 2022 May 9.

DOI:10.1038/s41574-022-00675-6
PMID:35534573
Abstract

Macrophages have diverse phenotypes and functions due to differences in their origin, location and pathophysiological context. Although their main role in the liver has been described as immunoregulatory and detoxifying, changes in macrophage phenotypes, diversity, dynamics and function have been reported during obesity-related complications such as non-alcoholic fatty liver disease (NAFLD). NAFLD encompasses multiple disease states from hepatic steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocarcinoma. Obesity and insulin resistance are prominent risk factors for NASH, a disease with a high worldwide prevalence and no approved treatment. In this Review, we discuss the turnover and function of liver-resident macrophages (Kupffer cells) and monocyte-derived hepatic macrophages. We examine these populations in both steady state and during NAFLD, with an emphasis on NASH. The explosion in high-throughput gene expression analysis using single-cell RNA sequencing (scRNA-seq) within the last 5 years has revolutionized the study of macrophage heterogeneity, substantially increasing our understanding of the composition and diversity of tissue macrophages, including in the liver. Here, we highlight scRNA-seq findings from the last 5 years on the diversity of liver macrophages in homeostasis and metabolic disease, and reveal hepatic macrophage function beyond their classically described inflammatory role in the progression of NAFLD and NASH pathogenesis.

摘要

巨噬细胞因其起源、位置和病理生理背景的不同而具有不同的表型和功能。尽管它们在肝脏中的主要作用是免疫调节和解毒,但在肥胖相关并发症(如非酒精性脂肪性肝病,NAFLD)中,巨噬细胞表型、多样性、动态和功能的变化已经被报道。NAFLD 包括从肝脂肪变性到非酒精性脂肪性肝炎(NASH)、纤维化、肝硬化和肝癌等多种疾病状态。肥胖和胰岛素抵抗是 NASH 的突出危险因素,这是一种在全球范围内发病率较高且尚无批准治疗方法的疾病。在这篇综述中,我们讨论了肝脏驻留巨噬细胞(Kupffer 细胞)和单核细胞衍生的肝巨噬细胞的更新和功能。我们在稳态和 NAFLD 期间检查了这些细胞群,重点是 NASH。在过去的 5 年中,利用单细胞 RNA 测序(scRNA-seq)进行高通量基因表达分析的爆炸式发展彻底改变了对巨噬细胞异质性的研究,大大提高了我们对组织巨噬细胞组成和多样性的理解,包括在肝脏中。在这里,我们强调了过去 5 年中关于稳态和代谢性疾病中肝脏巨噬细胞多样性的 scRNA-seq 研究结果,并揭示了肝巨噬细胞的功能超越了其在 NAFLD 和 NASH 发病机制进展中经典描述的炎症作用。

相似文献

1
Macrophage functional diversity in NAFLD - more than inflammation.非酒精性脂肪性肝病中巨噬细胞的功能多样性——不止炎症那么简单。
Nat Rev Endocrinol. 2022 Aug;18(8):461-472. doi: 10.1038/s41574-022-00675-6. Epub 2022 May 9.
2
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.巨噬细胞衍生的血小板反应蛋白1促进肥胖相关的非酒精性脂肪性肝病。
JHEP Rep. 2020 Oct 9;3(1):100193. doi: 10.1016/j.jhepr.2020.100193. eCollection 2021 Feb.
3
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪组织胰岛素抵抗与肝巨噬细胞的串扰。
J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10.
4
CD44 is a key player in non-alcoholic steatohepatitis.CD44 是非酒精性脂肪性肝炎的关键参与者。
J Hepatol. 2017 Aug;67(2):328-338. doi: 10.1016/j.jhep.2017.03.003. Epub 2017 Mar 16.
5
[Macrophage heterogeneity role in NAFLD and NASH disease progression].[巨噬细胞异质性在非酒精性脂肪性肝病和非酒精性脂肪性肝炎疾病进展中的作用]
Zhonghua Gan Zang Bing Za Zhi. 2023 Jul 20;31(7):770-775. doi: 10.3760/cma.j.cn501113-20220428-00223.
6
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis.巨噬细胞在非酒精性脂肪性肝病发病机制中的多方面作用。
Cell Mol Gastroenterol Hepatol. 2023;15(6):1311-1324. doi: 10.1016/j.jcmgh.2023.03.002. Epub 2023 Mar 11.
7
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.非酒精性脂肪性肝病与胰岛素抵抗:新见解及潜在新疗法
Nutrients. 2017 Apr 14;9(4):387. doi: 10.3390/nu9040387.
8
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.高强度运动可改善肝脏炎症和 NASH 的进展。
Mol Metab. 2021 Nov;53:101270. doi: 10.1016/j.molmet.2021.101270. Epub 2021 Jun 10.
9
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.巨噬细胞清道夫受体1介导非酒精性脂肪性肝病中的脂质诱导炎症。
J Hepatol. 2022 May;76(5):1001-1012. doi: 10.1016/j.jhep.2021.12.012. Epub 2021 Dec 21.
10
Single Cell RNA Sequencing in NASH.非酒精性脂肪性肝炎的单细胞 RNA 测序。
Methods Mol Biol. 2022;2455:181-202. doi: 10.1007/978-1-0716-2128-8_15.

引用本文的文献

1
From "Traditional" to "Trained" Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).从“传统”免疫到“训练有素”的免疫:探索代谢功能障碍相关脂肪性肝病(MASLD)进展中免疫发病机制的新前沿
Biomedicines. 2025 Aug 18;13(8):2004. doi: 10.3390/biomedicines13082004.
2
Single-Cell Transcriptomic Analysis of Different Liver Fibrosis Models: Elucidating Molecular Distinctions and Commonalities.不同肝纤维化模型的单细胞转录组分析:阐明分子差异与共性
Biomedicines. 2025 Jul 22;13(8):1788. doi: 10.3390/biomedicines13081788.
3
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.

本文引用的文献

1
Single-Cell, Single-Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity.单细胞、单细胞核和空间 RNA 测序鉴定人类肝脏中的胆管细胞和间充质异质性。
Hepatol Commun. 2022 Apr;6(4):821-840. doi: 10.1002/hep4.1854. Epub 2021 Nov 18.
2
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.随机、对照试验研究泛 PPAR 激动剂 Lanifibranor 在 NASH 中的作用。
N Engl J Med. 2021 Oct 21;385(17):1547-1558. doi: 10.1056/NEJMoa2036205.
3
A subset of Kupffer cells regulates metabolism through the expression of CD36.
逐渐发生的DNA甲基化变化揭示了与代谢功能障碍相关的脂肪性肝病进展和表观遗传年龄加速有关的转录因子。
Clin Epigenetics. 2025 Aug 4;17(1):138. doi: 10.1186/s13148-025-01945-6.
4
Integrated Single-Cell Analysis Dissects Regulatory Mechanisms Underlying Tumor-Associated Macrophage Plasticity in Hepatocellular Carcinoma.整合单细胞分析揭示肝细胞癌中肿瘤相关巨噬细胞可塑性的调控机制
Genes (Basel). 2025 Jul 12;16(7):817. doi: 10.3390/genes16070817.
5
Myeloid cells in chronic liver inflammation.慢性肝脏炎症中的髓样细胞。
Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4.
6
Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives.活性氧作为酒精性脂肪性肝病和非酒精性脂肪性肝病发病机制中的关键分子:未来展望
Curr Issues Mol Biol. 2025 Jun 17;47(6):464. doi: 10.3390/cimb47060464.
7
C/EBPβ-VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD.库普弗细胞中的C/EBPβ-VCAM1轴促进非酒精性脂肪性肝病相关脂肪性肝炎中的肝脏炎症。
JHEP Rep. 2025 Apr 15;7(8):101418. doi: 10.1016/j.jhepr.2025.101418. eCollection 2025 Aug.
8
Proteomics and cytokine array jointly reveal the role of macrophage proinflammatory shift in liver fibrosis in dairy cows with ketosis.蛋白质组学和细胞因子阵列联合揭示巨噬细胞促炎转变在酮病奶牛肝纤维化中的作用。
J Anim Sci Biotechnol. 2025 Jul 8;16(1):97. doi: 10.1186/s40104-025-01219-4.
9
Association of High-Density Lipoprotein Cholesterol-Based Inflammatory Markers With MASLD and Significant Liver Fibrosis in US Adults: Insights From NHANES 2017-2020.美国成年人中基于高密度脂蛋白胆固醇的炎症标志物与代谢功能障碍相关脂肪性肝病及显著肝纤维化的关联:来自2017 - 2020年美国国家健康与营养检查调查的见解
Clin Transl Gastroenterol. 2025 Jun 16. doi: 10.14309/ctg.0000000000000873.
10
Trends and Hot Spots of Macrophages Linked to Metabolic Syndrome: A Comprehensive Bibliometric and Visualization Analysis (2014-2024).与代谢综合征相关的巨噬细胞研究趋势与热点:一项全面的文献计量学与可视化分析(2014 - 2024年)
Mediators Inflamm. 2025 May 24;2025:9487093. doi: 10.1155/mi/9487093. eCollection 2025.
一组库普弗细胞通过表达 CD36 来调节代谢。
Immunity. 2021 Sep 14;54(9):2101-2116.e6. doi: 10.1016/j.immuni.2021.08.006. Epub 2021 Aug 31.
4
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming.鉴定能够逆转肝细胞预激活诱导的 T 细胞功能障碍的枯否细胞亚群。
Immunity. 2021 Sep 14;54(9):2089-2100.e8. doi: 10.1016/j.immuni.2021.05.005. Epub 2021 Aug 31.
5
Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity.肝 miR-144 驱动延胡索酸酶活性,防止肥胖期间 NRF2 的激活。
Gastroenterology. 2021 Dec;161(6):1982-1997.e11. doi: 10.1053/j.gastro.2021.08.030. Epub 2021 Aug 21.
6
XCR1 type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.XCR1 型 1 类传统树突状细胞驱动非酒精性脂肪性肝炎的肝脏病变。
Nat Med. 2021 Jun;27(6):1043-1054. doi: 10.1038/s41591-021-01344-3. Epub 2021 May 20.
7
A single cell gene expression atlas of 28 human livers.28个人类肝脏的单细胞基因表达图谱
J Hepatol. 2021 Jul;75(1):219-220. doi: 10.1016/j.jhep.2021.03.005. Epub 2021 May 18.
8
Genetic fate-mapping reveals surface accumulation but not deep organ invasion of pleural and peritoneal cavity macrophages following injury.遗传命运图谱揭示了损伤后胸膜和腹膜腔巨噬细胞的表面积累,但不包括深部器官浸润。
Nat Commun. 2021 May 17;12(1):2863. doi: 10.1038/s41467-021-23197-7.
9
Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis.Galectin-3 抑制剂治疗非酒精性脂肪性肝炎的研究进展。
Expert Rev Clin Pharmacol. 2021 Apr;14(4):457-464. doi: 10.1080/17512433.2021.1894127. Epub 2021 Mar 2.
10
Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH.动态变化的驻留巨噬细胞和募集巨噬细胞组成影响 NASH 组织重塑。
Cell Rep. 2021 Jan 12;34(2):108626. doi: 10.1016/j.celrep.2020.108626.